Nanopublications LDF server

Matches in Nanopublications for { ?s ?p "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }

• assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP892508.RAV_dj3Io0NMrLEWqd_LzUSqac_MDN8WQdZdlyGFs2-GQ130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892508.RAV_dj3Io0NMrLEWqd_LzUSqac_MDN8WQdZdlyGFs2-GQ130_provenance.
• assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
• NP559797.RADg0hHNy5HFawzMt_VGDEvzlmKZhh8jGeV45scs7Se7Q130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559797.RADg0hHNy5HFawzMt_VGDEvzlmKZhh8jGeV45scs7Se7Q130_provenance.
• NP559796.RAeq0cOQZw3T6zjLvFl3aMQRA7_rDPPLEOUM4b5OfzWfo130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559796.RAeq0cOQZw3T6zjLvFl3aMQRA7_rDPPLEOUM4b5OfzWfo130_provenance.
• NP449440.RAv5SCa0DzI7Ps6IMsmK3koGb__sn3SrbFbb2tuAqYFu8130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449440.RAv5SCa0DzI7Ps6IMsmK3koGb__sn3SrbFbb2tuAqYFu8130_provenance.
• NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892553.RAhc7hH_wQhw1GZmYU5FfdAEhQNemkV7jJGl-a45L-l1s130_provenance.
• NP892590.RAnDfOW9dYZu3oH9OFksKyVy8lmVB2r-8KmNqmncKnUJg130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP892590.RAnDfOW9dYZu3oH9OFksKyVy8lmVB2r-8KmNqmncKnUJg130_provenance.
• NP559793.RAo7ABbN5twvL9GI9l0SNYGyhPg-FpAfUKOhRBWlw6KWI130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559793.RAo7ABbN5twvL9GI9l0SNYGyhPg-FpAfUKOhRBWlw6KWI130_provenance.
• NP449574.RA1_WgKhIv9bSA8PGCplGKJ_S5X_Ra3rcmRPnNaHbcFKo130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP449574.RA1_WgKhIv9bSA8PGCplGKJ_S5X_Ra3rcmRPnNaHbcFKo130_provenance.
• NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559794.RAHoOY6SmpWBPon2nrVX7_oqN5n3yS0QzYen_4Kt4NhPI130_provenance.
• NP559795.RAMUOf3wxhSFXYD9V8bBVAOtZNC8hOcgeH72ogdELQaZQ130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559795.RAMUOf3wxhSFXYD9V8bBVAOtZNC8hOcgeH72ogdELQaZQ130_provenance.
• NP559792.RA2lMWRR9P2pLCpFhCC9rwcgMGrVanrZbgUM3oDAa8CNU130_assertion description "[Potent natural product-derived HIF-1 activators that exhibit a low level of toxicity and side effects hold promise as new treatment options for diseases such as myocardial and peripheral ischemia, and as chemopreventative agents that could be used to reduce the level of ischemia/reperfusion injury following heart attack and stroke.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP559792.RA2lMWRR9P2pLCpFhCC9rwcgMGrVanrZbgUM3oDAa8CNU130_provenance.